{"id":33304,"date":"2026-04-01T08:51:52","date_gmt":"2026-04-01T08:51:52","guid":{"rendered":"https:\/\/christiancorner.us\/index.php\/2026\/04\/01\/novo-nordisk-stock-rises-after-uk-drug-pricing-regulator-recommends-wegovi\/"},"modified":"2026-04-01T08:52:05","modified_gmt":"2026-04-01T08:52:05","slug":"novo-nordisk-stock-rises-after-uk-drug-pricing-regulator-recommends-wegovi","status":"publish","type":"post","link":"https:\/\/christiancorner.us\/index.php\/2026\/04\/01\/novo-nordisk-stock-rises-after-uk-drug-pricing-regulator-recommends-wegovi\/","title":{"rendered":"Novo Nordisk stock rises after UK drug pricing regulator recommends Wegovi"},"content":{"rendered":"<p>\n<\/p>\n<div id=\"RegularArticle-ArticleBody-5\" data-module=\"ArticleBody\" data-test=\"articleBody-2\" data-analytics=\"RegularArticle-articleBody-5-2\"><span class=\"HighlightShare-hidden\" style=\"top:0;left:0\"\/><\/p>\n<div class=\"InlineImage-imageEmbed\" id=\"ArticleBody-InlineImage-108279913\" data-test=\"InlineImage\">\n<div class=\"InlineImage-wrapper\">\n<div>\n<p>Michael Siluk | UCG | Universal Images Group | getty images<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"group\">\n<p><span class=\"QuoteInBody-quoteNameContainer\" data-test=\"QuoteInBody\" id=\"RegularArticle-QuoteInBody-1\">Novo Nordisk<span class=\"QuoteInBody-inlineButton\"><span class=\"AddToWatchlistButton-watchlistContainer\" id=\"-WatchlistDropdown\" data-analytics-id=\"-WatchlistDropdown\"><button class=\"AddToWatchlistButton-watchlistButton\" aria-label=\"Add To Watchlist\" data-testid=\"dropdown-btn\"><span class=\"AddToWatchlistButton-addWatchListFromTag\"\/><\/button><\/span><\/span><\/span>    They rose as much as 4% after England&#8217;s drug price regulator recommended the use of its best-selling drug Vegovi to prevent heart attacks and strokes. <\/p>\n<p>Vegovy is primarily a weight loss treatment, but it is also approved to reduce the risk of major cardiovascular events in people who are overweight or obese. <\/p>\n<p>The new recommendation from England&#8217;s drug pricing regulator National Institute for Health and Care Excellence (NICE) will significantly expand access to Wegovi on the country&#8217;s National Health Service (NHS). <\/p>\n<p>The regulator, which assesses a medicine&#8217;s cost-effectiveness, has recommended semaglutide, the active ingredient in Vegovy and the diabetes treatment Ozempic, as an option for adults who have had a previous heart attack, stroke, or severe circulation problems in the legs and who have a body mass index (BMI) of at least 27.<\/p>\n<p>Novo&#8217;s Copenhagen-listed shares were last seen up 2% in morning trading, paring some of the earlier gains. Pan-European Blue-Chip Index <span class=\"QuoteInBody-quoteNameContainer\" data-test=\"QuoteInBody\" id=\"RegularArticle-QuoteInBody-3\">stoxx 600<span class=\"QuoteInBody-inlineButton\"><span class=\"AddToWatchlistButton-watchlistContainer\" id=\"-WatchlistDropdown\" data-analytics-id=\"-WatchlistDropdown\"><button class=\"AddToWatchlistButton-watchlistButton\" aria-label=\"Add To Watchlist\" data-testid=\"dropdown-btn\"><span class=\"AddToWatchlistButton-addWatchListFromTag\"\/><\/button><\/span><\/span><\/span>    was up 2.1%.<\/p>\n<p><em><strong>This is a breaking news story. Please refresh for updates.<\/strong><\/em><\/p>\n<\/div>\n<div class=\"ArticleBody-googlePreferredSourceContainer\" data-module=\"GooglePreferredSource\" data-id=\"RegularArticle-GooglePreferredSource-5\">Choose CNBC as your favorite source on Google and never miss a moment of the most trusted name in business news.<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Michael Siluk | UCG | Universal Images Group | getty images Novo Nordisk They rose as much as 4% after England&#8217;s drug price regulator recommended the use of its best-selling drug Vegovi to prevent heart attacks and strokes. Vegovy is primarily a weight loss treatment, but it is also approved to reduce the risk of<\/p>\n","protected":false},"author":1,"featured_media":33305,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[56],"tags":[2878,7680,7679,1544,13975,1675,1657,1265,13464],"class_list":["post-33304","post","type-post","status-publish","format-standard","has-post-thumbnail","category-bible-news","tag-drug","tag-nordisk","tag-novo","tag-pricing","tag-recommends","tag-regulator","tag-rises","tag-stock","tag-wegovi"],"_links":{"self":[{"href":"https:\/\/christiancorner.us\/index.php\/wp-json\/wp\/v2\/posts\/33304","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/christiancorner.us\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/christiancorner.us\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/christiancorner.us\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/christiancorner.us\/index.php\/wp-json\/wp\/v2\/comments?post=33304"}],"version-history":[{"count":1,"href":"https:\/\/christiancorner.us\/index.php\/wp-json\/wp\/v2\/posts\/33304\/revisions"}],"predecessor-version":[{"id":33306,"href":"https:\/\/christiancorner.us\/index.php\/wp-json\/wp\/v2\/posts\/33304\/revisions\/33306"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/christiancorner.us\/index.php\/wp-json\/wp\/v2\/media\/33305"}],"wp:attachment":[{"href":"https:\/\/christiancorner.us\/index.php\/wp-json\/wp\/v2\/media?parent=33304"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/christiancorner.us\/index.php\/wp-json\/wp\/v2\/categories?post=33304"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/christiancorner.us\/index.php\/wp-json\/wp\/v2\/tags?post=33304"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}